da Vinci SP 系统机器人肝切除的可行性与围术期安全性:早期单中心病例系列
结论认为该技术在经选择的患者中可行,围术期风险未见明显增加。
要点
- da Vinci SP系统机器人肝切除在经选择的患者中可行,无中转开腹或术中输血。
- 主要并发症发生率低,本系列仅1例十二指肠溃疡出血需内镜止血。
- 无胆漏、肝衰竭、出血、再入院或30天死亡,恶性肿瘤均获R0切除。
核心结论
- 在早期单中心病例系列中,使用da Vinci SP系统行机器人肝切除在经仔细选择的患者中可行,围术期风险未见明显增加。
- 研究结果为描述性、假设生成性,需更大规模多中心前瞻性研究明确da Vinci SP在肝胆外科的临床价值与最佳角色。
研究设计与样本
- 预设安全性终点包括中转、术中输血、Clavien-Dindo≥IIIa级并发症、胆漏、术后肝衰竭、术后出血、再入院及30天死亡。
- 胆漏、肝衰竭和术后出血按国际肝脏外科研究组标准定义。
主要发现
- 20例患者中位年龄74岁(范围25-87),肿瘤大小1.9 cm(范围0.8-11.0),Iwate难度评分5(范围2-11)。
- 17例采用SP-plus-one入路,3例采用纯SP入路;8例行解剖性切除,包括4例半肝切除。
- 无中转开腹或术中输血;1例发生主要并发症(十二指肠溃疡出血需内镜止血)。
- 无胆漏、术后肝衰竭、术后出血、再入院或30天死亡;所有恶性肿瘤病例均获R0切除。
- 中位手术时间283 min(范围123-575),估计失血量33 mL(范围5-200),术后住院7.5天(范围4-11)。
临床怎么用
- 对于经选择的患者,da Vinci SP系统机器人肝切除可作为可选术式,早期开展时需关注预设安全性终点。
- SP-plus-one入路是本系列主要采用的技术方式,纯SP入路也可在部分病例中应用。
局限性
- 回顾性单中心小样本病例系列,结果仅为描述性,不能用于推断因果关系或与其他术式比较。
- 早期开展阶段的选择偏倚可能存在,且缺乏长期肿瘤学结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical evidence for robotic liver resection (RLR) using the da Vinci SP™ system remains limited, particularly regarding perioperative outcomes during early implementation. We report an early single-center case series of RLR using the da Vinci SP system, primarily performed with a single-port (SP) -plus-one approach. METHODS: This retrospective study included consecutive patients who underwent RLR using the da Vinci SP system at a single institution. Prespecified safety endpoints were conversion, intraoperative transfusion, major complications (Clavien-Dindo grade ≥ IIIa), bile leakage, posthepatectomy liver failure (PHLF), posthepatectomy hemorrhage (PHH), readmission, and 30-day mortality. Bile leakage, PHLF, and PHH were defined according to International Study Group of Liver Surgery criteria. Operative metrics, postoperative stay, and margin status were also assessed. RESULTS: Between October 2024 and December 2025, 20 patients underwent RLR using the da Vinci SP system. Median age was 74 years (range, 25-87), tumor size was 1.9 cm (range, 0.8-11.0), and Iwate difficulty score was 5 (range, 2-11). An SP-plus-one approach was used in 17 cases, whereas a true SP approach was used in 3. Anatomical resection was performed in eight patients, including four hemihepatectomies. No conversions or intraoperative transfusions were required. One patient experienced a major complication (duodenal ulcer bleeding requiring endoscopic hemostasis). No bile leakage, PHLF, PHH, readmissions, or 30-day mortality occurred. Median operative time was 283 min (range, 123-575), estimated blood loss was 33 mL (range, 5-200), and postoperative stay was 7.5 days (range, 4-11). R0 resection was achieved in all malignant cases. CONCLUSIONS: In this early single-center case series, RLR using the da Vinci SP system was feasible in carefully selected patients, with no apparent increase in perioperative risk. These findings are descriptive and hypothesis-generating; larger multicenter prospective studies are warranted to define the clinical value and optimal role of the da Vinci SP in hepatobiliary surgery.
引用
- Murakami T, Imamura M, Okuya K, et al. Feasibility and perioperative safety of robotic liver resection using the da Vinci SP system: early single-center case series. Surg Endosc. 2026. PMID: 42387007. doi:10.1007/s00464-026-13055-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。